Viewing StudyNCT05861830



Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05861830
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2023-05-07

Brief Title: Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK46 Inhibitor Failure DAWNA-FES
Sponsor: Peking Union Medical College Hospital
Organization: Peking Union Medical College Hospital

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-15
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2023-05-07
First Submit QC Date: May 7 2023
Study First Post Date: 2023-05-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-10
Last Update Post Date: 2024-03-12
Last Update Post Date Type: ACTUAL